Publicaciones científicas
European position statement on lung cancer screening
Matthijs Oudkerk 1 , Anand Devaraj 2 , Rozemarijn Vliegenthart 1 , Thomas Henzler 3 , Helmut Prosch 4 , Claus P Heussel 5 , Gorka Bastarrika 6 , Nicola Sverzellati 7 , Mario Mascalchi 8 , Stefan Delorme 9 , David R Baldwin 10 , Matthew E Callister 11 , Nikolaus Becker 12 , Marjolein A Heuvelmans 1 , Witold Rzyman 13 , Maurizio V Infante 14 , Ugo Pastorino 15 , Jesper H Pedersen 16 , Eugenio Paci 17 , Stephen W Duffy 18 , Harry de Koning 19 , John K Field 20
Abstract
Lung cancer screening with low-dose CT can save lives. This European Union (EU) position statement presents the available evidence and the major issues that need to be addressed to ensure the successful implementation of low-dose CT lung cancer screening in Europe.
This statement identified specific actions required by the European lung cancer screening community to adopt before the implementation of low-dose CT lung cancer screening.
This position statement recommends the following actions: a risk stratification approach should be used for future lung cancer low-dose CT programmes; that individuals who enter screening programmes should be provided with information on the benefits and harms of screening, and smoking cessation should be offered to all current smokers; that management of detected solid nodules should use semi-automatically measured volume and volume-doubling time; that national quality assurance boards should be set up to oversee technical standards; that a lung nodule management pathway should be established and incorporated into clinical practice with a tailored screening approach; that non-calcified baseline lung nodules greater than 300 mm3, and new lung nodules greater than 200 mm3, should be managed in multidisciplinary teams according to this EU position statement recommendations to ensure that patients receive the most appropriate treatment; and planning for implementation of low-dose CT screening should start throughout Europe as soon as possible. European countries need to set a timeline for implementing lung cancer screening.
CITA DEL ARTÍCULO Lancet Oncol. 2017 Dec;18(12):e754-e766. doi: 10.1016/S1470-2045(17)30861-6.
Nuestros autores
